Regular ArticleIn Vitro Metabolism of CP-122,721 ((2S,3S)-2-Phenyl-3-[(5-Trifluoromethoxy-2-Methoxy)Benzylamino]Piperidine), a Non-Peptide Antagonist of the Substance P Receptor
References (33)
- et al.
Synthesis and structure-activity relationships of CP-122,721, a second-generation NK-1 receptor antagonist
Bioorg. Med. Chem. Lett
(1998) - et al.
Kinetic isotope effects on cytochrome P-450 catalyzed oxidation reactions: full expression of the intrinsic isotope effect during the O-deethylation of 7-ethoxycoumarin by liver microsomes from 3-methylcholanthrene-induced hamsters
Arch. Biochem. Biophys.
(1985) - et al.
Novel metabolic pathway of arylethers by cytochrome P450: cleavage of the oxygen-aromatic ring bond accompanying ipso-substitution by the oxygen atom of the active species in cytochrome P450 models and cytochrome P450
Arch. Biochem. Biophys.
(1994) - et al.
Novel oxidative pathway of para-substituted phenols in cytochrome P450 chemical model: substituent elimination accompanying ipso-substitution by the oxygen atom of the active species
Tet. Lett.
(1995) - et al.
Ipso-substitution by cytochrome P450 with conversion of p-hydroxybenzene derivatives to hydroquinone: evidence for hydroperoxoiron as the active oxygen species
Arch. Biochem. Biophys.
(2002) - et al.
Single dose kinetics of thioridazine and its two psychoactive metabolites in healthy humans: a dose proportionality study
J. Pharm. Sci.
(1989) - et al.
Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptor
J. Pharmacol. Exp. Ther.
(1996) - et al.
Use of an NK1 receptor antagonist to prevent delayed emesis after cisplatin
J. Nat. Cancer Inst.
(1997) - et al.
Distinct mechanism for antidepressant activity by blockade of central substance P receptors
Science
(1998) - et al.
Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis
J. Clin. Oncol.
(1999)
Substance P (neurokinin-1) antagonist prevents postoperative vomiting after abdominal hysterectomy procedures
Anesthesiology
(2000)
The carbon monoxide binding pigment of liver microsomes
J. Biol. Chem.
(1964)
Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance
J. Pharmacokinet. Biopharm.
(1977)
The conduct of in vitro and in vivo drug-drug interaction studies: A Pharmaceutical Research and Manufacturers of America (PhRMA) perspective
Drug Metab. Dispos.
(2003)
Antiarrythmics
Inhibition of CYP3A catalyzed 1′-hydroxymidazolam formation by ketoconazole, nifedipine, erythromycin, cimetidine, and nizatidine
Pharm. Res.
(1994)
Cited by (12)
Predicting oxidation sites with order of occurrence among multiple sites for CYP4A-mediated reactions
2011, Drug Metabolism and PharmacokineticsNew trends in the chemistry of α-fluorinated ethers, thioethers, amines and phosphines
2010, Journal of Fluorine ChemistryDiscovery and stereoselective synthesis of the novel isochroman neurokinin-1 receptor antagonist 'CJ-17,493'
2008, Bioorganic and Medicinal ChemistryThe Importance of Tracking “Missing” Metabolites: How and Why?
2023, Journal of Medicinal ChemistryHuman Absorption, Distribution, Metabolism, and Excretion Studies: Origins, Innovations, and Importance
2023, Drug Metabolism and DispositionAn Introduction to Metabolic Reaction-Phenotyping
2022, DRUG METABOLISM HANDBOOK: CONCEPTS AND APPLICATIONS IN CANCER RESEARCH
Copyright © 2007 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.